Pressure Injury Development, Mitigation, and Outcomes of Patients Proned for Acute Respiratory Distress Syndrome.


Journal

Advances in skin & wound care
ISSN: 1538-8654
Titre abrégé: Adv Skin Wound Care
Pays: United States
ID NLM: 100911021

Informations de publication

Date de publication:
01 Apr 2022
Historique:
pubmed: 27 7 2021
medline: 24 3 2022
entrez: 26 7 2021
Statut: ppublish

Résumé

To describe trends and risk factors for pressure injuries (PIs) in adult critical care patients proned to alleviate acute respiratory distress syndrome secondary to COVID-19 and examine the effectiveness of products and strategies used to mitigate PIs. The authors conducted a retrospective chart review between April 9 and June 8, 2020. Demographic data were analyzed using descriptive statistics. Differences between groups with and without PIs were analyzed. Among 147 patients, significant PI risk factors included male sex (P = .019), high body mass index (>40 kg/m2; P = .020), low Braden Scale score (<12; P = .018), and low-dose vasopressor therapy (P = .020). Taping endotracheal tubes (ETTs) caused significantly fewer facial PIs than commercial ETT holders (P < .0001). Maximum prone duration/session was a significant risk factor for anterior PIs (P = .016), which dropped 71% with newer pressure redistribution products. d-Dimer greater than 3,200 μg/mL (P = .042) was a significant risk factor for sacrococcygeal PIs while supine. Mortality was 30%; significant risk factors included age older than 60 years (P = .005), Sequential Organ Failure Assessment score greater than 11 (P = .003), and comorbid congestive heart failure (P = .016). Taping the ETT, limiting the maximum duration of prone positioning to less than 32 hours, and frequent repositioning while supine may reduce the number of modifiable risk factors for PIs. Standardized methods for testing products for PI prevention will inform individualized patient care.

Identifiants

pubmed: 34310362
doi: 10.1097/01.ASW.0000767404.02594.85
pii: 00129334-202204000-00005
doi:

Types de publication

Journal Article

Langues

eng

Pagination

202-212

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Al-Samkari H, Leaf RSK, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 2020;136:489–500.
Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 2020;8:152.
Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res 2020;30:367–9.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 2020;324:782–93.
Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020;383:120–8.
Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62.
Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Nander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med 2020;8:681–6.
Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020;220:1–13.
Black J, Cuddigan J; National Pressure Injury Advisory Panel Board of Directors. Skin manifestations with COVID-19: The purple skin and toes that you are seeing may not be deep tissue pressure injury. An NPIAP White Paper. 2020. https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/COVID_Skin_Manifestations_An.pdf . Last accessed July 8, 2021.
Halpern NA, Kaplan LJ, Rausen M, Yang JJ. Configuring ICUs in the COVID-19 Era. Society for Critical Care Medicine. www.sccm.org/COVID19RapidResources/Resources/Configuring-ICUs-in-the-COVID-19-Era-A-Collection . Last accessed July 8, 2021.
Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 2004;292:2379–87.
Griffiths MJD, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res 2019;6:e000420.
Coleman S, Nixon J, Keen J, et al. A new pressure ulcer conceptual framework. J Adv Nurs 2014;70:2222–34.
European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel, and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline. The International Guideline. Haesler E, ed.  EPUAP/NPIAP/PPPIA; 2019.
Cox J. Predictors of pressure ulcers in adult critical care patients. Am J Crit Care 2011;20:364–75.
Labeau SO, Afonso E, Benbenishty J, et al. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study. Intensive Care Med 2021;47:160–9.
Sala JJ, Mayampurath A, Solmos S, et al. Predictors of pressure injury development in critically ill adults: a retrospective cohort study. Intensive Crit Care Nurs 2021;62:102924.
Universal Hospital Services, Inc. User-Service Manual: Dolphin Fluid Immersion Simulation System. Edina, MN: UHS; 2012.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
Medlej K. Sequential Organ Failure Assessment (SOFA) Score. Emerg Med Pract 2018;October:CD1-6.
Bergstrom N, Braden BJ, Laguzza A, Holman V. The Braden Scale for predicting pressure sore risk. Nurs Res 1987;36:205–10.
Kring DL. Reliability and validity of the Braden Scale for predicting pressure ulcer risk. J Wound Ostomy Continence Nurs 2007;34:399–406.
Ho CH, Cheung A, Southern D, et al. A mixed-methods study to assess interrater reliability and nurse perception of the Braden Scale in a tertiary acute care setting. Ostomy Wound Manage 2016;62:30–8.
ASPT TRACIE. SOFA Score: What it is and how to use it in triage. June 2017. https://asprtracie.hhs.gov/MasterSearch?qt=sofa&limit=20&page=1&CurTab=0 . Last accessed July 8, 2021.
Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793–800.
Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754–8.
Riviello ED, Kiviri W, Twagirumugabe T, et al. Hospital incidence and outcomes of the acute respiratory distress syndrome using the Kigali Modification of the Berlin definition. Am J Respir Crit Care Med 2016;193:52–9.
Favaloro EJ, Thachil J. Reporting of d -dimer data in COVID-19: some confusion and potential for misinformation. Clin Chem Lab Med 2020;58:1191–9.
Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368:2159–68.
Capasso V, Cox J, Cuddigan J, Delmore B, Tescher A, Solmos S. PIP Tips for Prone Positioning. 2020. https://cdn.ymaws.com/npiap.com/resource/resmgr/online_store/posters/npiap_pip_tips_-_proning_202.pdf . Last accessed July 8, 2021.
Oudit GY, Pfeffer MA. Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19. Eur Heart J 2020;41:1818–20.
Takahashi T, Ellingson MK, Wong P, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 2020;588:315–20.
Bwire GM. Coronavirus: why men are more vulnerable to COVID-19 than women?SN Compr Clin Med 2020;1–3.
Belanger MJ, Hill MA, Angelidi A, Dalamaga M, Sowers JR, Mantzoros CS. COVID-19 and disparities in nutrition and obesity. N Engl J Med 2020;383:e69.
Cook TM. The importance of hypertension as a risk factor for severe illness and mortality in COVID-19. Anesthesia 2020;75:976–7.
Satter N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection. Circulation 2020;142:4–6.

Auteurs

Virginia Capasso (V)

At Massachusetts General Hospital in Boston, Virginia Capasso, PhD, CNP, ACNS-BC, CWS, FACCWS, is Nurse Scientist, Yvonne L. Munn Center for Nursing Research; Colleen Snydeman, PhD, RN, is Executive Director; Karen Miguel, MM-H, RN, is Staff Specialist; Xianghong Wang, MS, is Senior Analyst; Michelle Crocker, BSN, RN, is Staff Nurse, Cardiac ICU; Zachary Chornoby, BSN, RN, CCRN, is Staff Nurse, Cardiac ICU; Mark Vangel, PhD, is Statistician, Marino Center for Radiology; Mary Ann Walsh, BSN, RN, is Nurse Clinician; John Murphy, DNP, RN, is Staff Specialist, Center for Quality & Safety; and Stephanie Qualls, MSN, RN, is Clinical Nurse Specialist, Neuroscience ICU.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH